CHEBI:18095 - trans-4-hydroxy-L-proline

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name trans-4-hydroxy-L-proline
ChEBI ID CHEBI:18095
ChEBI ASCII Name trans-4-hydroxy-L-proline
Definition An optically active form of 4-hydroxyproline having L-trans-configuration.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:43318, CHEBI:43172, CHEBI:43210, CHEBI:43227, CHEBI:49360, CHEBI:10714, CHEBI:27060, CHEBI:12864
Supplier Information ChemicalBook:CB8357870, eMolecules:521697, ZINC000000901791
Download Molfile XML SDF
more structures >>
Formulae C5H9NO3
C5H9NO3
Net Charge 0
Average Mass 131.131
Monoisotopic Mass 131.05824
InChI InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1
InChIKey PMMYEEVYMWASQN-DMTCNVIQSA-N
SMILES [C@H]1(C[C@@H](O)CN1)C(O)=O
Metabolite of Species Details
Mus musculus (NCBI:txid10090) Source: BioModels - MODEL1507180067 See: PubMed
Arabidopsis thaliana (NCBI:txid3702) See: DOI
Homo sapiens (NCBI:txid9606) See: DOI
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
Biological Role(s): human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via 4-hydroxyproline )
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
plant metabolite
Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing trans-4-hydroxy-L-proline (CHEBI:18095) has role human metabolite (CHEBI:77746)
trans-4-hydroxy-L-proline (CHEBI:18095) has role mouse metabolite (CHEBI:75771)
trans-4-hydroxy-L-proline (CHEBI:18095) has role plant metabolite (CHEBI:76924)
trans-4-hydroxy-L-proline (CHEBI:18095) is a 4-hydroxyproline (CHEBI:20392)
trans-4-hydroxy-L-proline (CHEBI:18095) is tautomer of trans-4-hydroxy-L-proline zwitterion (CHEBI:58375)
Incoming (R)-4-hydroxy-1-methyl-L-proline (CHEBI:134543) has functional parent trans-4-hydroxy-L-proline (CHEBI:18095)
L-hydroxyproline 2-naphthylamide (CHEBI:90449) has functional parent trans-4-hydroxy-L-proline (CHEBI:18095)
Gly-Hyp (CHEBI:138515) has functional parent trans-4-hydroxy-L-proline (CHEBI:18095)
Pro-Hyp (CHEBI:74767) has functional parent trans-4-hydroxy-L-proline (CHEBI:18095)
trans-4-hydroxy-L-proline residue (CHEBI:61965) is substituent group from trans-4-hydroxy-L-proline (CHEBI:18095)
trans-4-hydroxy-L-proline zwitterion (CHEBI:58375) is tautomer of trans-4-hydroxy-L-proline (CHEBI:18095)
IUPAC Name
(4R)-4-hydroxy-L-proline
Synonyms Sources
(2S,4R)-4-hydroxy-2-pyrrolidinecarboxylic acid ChEBI
(2S,4R)-trans-4-hydroxyproline ChEBI
δ-hydroxyproline NIST Chemistry WebBook
Hydroxy-L-proline ChemIDplus
Hydroxyproline ChemIDplus
Hyp ChEBI
Hypro ChemIDplus
L-4-Hydroxyproline ChemIDplus
L-threo-4-hydroxyproline ChEBI
trans-4-hydroxy-L-proline ChEBI
trans-4-Hydroxy-L-proline KEGG COMPOUND
trans-Hydroxyproline NIST Chemistry WebBook
trans-L-Hydroxyproline NIST Chemistry WebBook
Manual Xrefs Databases
4-HYDROXY-L-PROLINE MetaCyc
4272 DrugCentral
C00001370 KNApSAcK
C01157 KEGG COMPOUND
HMDB0000725 HMDB
HYP PDBeChem
View more database links
Registry Numbers Types Sources
51-35-4 CAS Registry Number KEGG COMPOUND
51-35-4 CAS Registry Number ChemIDplus
51-35-4 CAS Registry Number NIST Chemistry WebBook
81441 Reaxys Registry Number Reaxys
Citations
Dong W, Zhang Y, Liu H, Gao B, Li D, Yang J (2009)
Detection of unsaturated disaccharides, pyridinoline, and hydroxyproline in urine of patients with Kashin-Beck disease: comparison with controls in an endemic area.
The Journal of rheumatology 36, 816-821 [PubMed:19286848]
[show Abstract]
Knight J, Jiang J, Assimos DG, Holmes RP (2006)
Hydroxyproline ingestion and urinary oxalate and glycolate excretion.
Kidney international 70, 1929-1934 [PubMed:17021603]
[show Abstract]
Açil Y, Mobasseri AE, Warnke PH, Terheyden H, Wiltfang J, Springer I (2005)
Detection of mature collagen in human dental enamel.
Calcified tissue international 76, 121-126 [PubMed:15558350]
[show Abstract]
Wittmann F, Prix N, Mayr S, Angele P, Wichmann MW, van den Engel NK, Hernandez-Richter T, Chaudry IH, Jauch KW, Angele MK (2005)
L-arginine improves wound healing after trauma-hemorrhage by increasing collagen synthesis.
The Journal of trauma 59, 162-168 [PubMed:16096557]
[show Abstract]
Silva BM, Casal S, Andrade PB, Seabra RM, Oliveira MB, Ferreira MA (2004)
Free amino acid composition of quince (Cydonia oblonga Miller) fruit (pulp and peel) and jam.
Journal of agricultural and food chemistry 52, 1201-1206 [PubMed:14995121]
[show Abstract]
Parker CR, Blackwell PJ, Freemont AJ, Hosking DJ (2002)
Biochemical measurements in the prediction of histologic subtype of renal transplant bone disease in women.
American journal of kidney diseases : the official journal of the National Kidney Foundation 40, 385-396 [PubMed:12148113]
[show Abstract]
Mazau D, Rumeau D, Esquerre-Tugaye MT (1988)
Two different families of hydroxyproline-rich glycoproteins in melon callus: biochemical and immunochemical studies.
Plant physiology 86, 540-546 [PubMed:16665943]
[show Abstract]
Niell HB, Palmieri GM, Neely CL, Maxwell TA, Hopkins SC, Soloway MS (1983)
Total, dialyzable, and nondialyzable postabsorptive hydroxyproline. Values in patients with cancer.
Archives of internal medicine 143, 1925-1927 [PubMed:6625779]
[show Abstract]
Niell HB, Neely CL, Palmieri GM, McDonald MW (1983)
The postabsorptive hydroxyproline in the long-term evaluation of patients with breast cancer.
Cancer 52, 1442-1447 [PubMed:6616407]
[show Abstract]
Niell HB, Palmieri GM, Neely CL, McDonald MW (1981)
Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer.
Archives of internal medicine 141, 1471-1473 [PubMed:7283558]
[show Abstract]
Dupuis Y, Digaud A, Gaudin-Harding F (1981)
Effect of vitamin D deficiency on urinary excretion of connective tissue derivatives (hydroxyproline and glycosaminoglycans) in rats.
Calcified tissue international 33, 177-180 [PubMed:6783274]
[show Abstract]
Niell HB, Neely CL, Palmieri GM (1981)
The postabsorptive urinary hydroxyproline (spot-HYPRO) in patients with multiple myeloma.
Cancer 48, 783-787 [PubMed:7248905]
[show Abstract]
van Holst GJ, Klis FM, de Wildt PJ, Hazenberg CA, Buijs J, Stegwee D (1981)
Arabinogalactan Protein from a Crude Cell Organelle Fraction of Phaseolus vulgaris L.
Plant physiology 68, 910-913 [PubMed:16662024]
[show Abstract]
Hey H, Tougaard L (1980)
Elevated bone phosphorus/hydroxyproline ratio following jejunoileal bypass surgery.
Acta medica Scandinavica 208, 321-323 [PubMed:7446210]
[show Abstract]
Tougaard L, Rickers H, Rödbro P, Thaysen EH, Christensen MS, Lund B, Sörensen OH (1977)
Bone composition and vitamin D after Pólya gastrectomy.
Acta medica Scandinavica 202, 47-50 [PubMed:899882]
[show Abstract]
Palmierj GM, Hawrylko J (1977)
Effects of aldosterone on the urinary excretion of total and non-dialyzable hydroxyproline.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 9, 507-509 [PubMed:590925]
[show Abstract]
Tougaard L, Buhl S, Poulsen H (1977)
The degree of bone mineralization in different parts of human skeleton estimated from bone phosphorus/hydroxyproline.
Scandinavian journal of clinical and laboratory investigation 37, 27-31 [PubMed:616023]
[show Abstract]
Tougaard L (1976)
The degree of bone mineralization in hyperthyroidism estimated from the phosphorus to hydroxyproline ratio in bone.
Acta endocrinologica 81, 482-486 [PubMed:946341]
[show Abstract]
Schaadt O, Tougaard L (1975)
The degree of bone mineralization in chronic renal failure estimated from phosphorus/hydroxyproline ratio in bone biopsies.
Acta medica Scandinavica 198, 91-93 [PubMed:1166829]
[show Abstract]
Harris ED, Hoffman GS, McGuire JL, Strosberg JM (1975)
Colchicine: effects upon urinary hydroxyproline excretion in patients with scleroderma.
Metabolism: clinical and experimental 24, 529-535 [PubMed:1117843]
[show Abstract]
Cleland R (1967)
Inhibition of formation of protein-bound hydroxyproline by free hydroxyproline in Avena coleoptiles.
Plant physiology 42, 1165-1170 [PubMed:16656634]
[show Abstract]
ROBERTSON WV (1964)
METABOLISM OF COLLAGEN IN MAMMALIAN TISSUES.
Biophysical journal 4, SUPPL93-114 [PubMed:14104082]
[show Abstract]
Last Modified
21 November 2019